Who invested in MedRhythms

3 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised 3 months ago

Funding summaryUpdated 26 Oct 2026

$9.3Mraised across 3 rounds since 2018, from 3 sources

$5.0MSeries A$3.3MVenture$1.0MRound

Latest round: Round, $1.0MAug 2026
Biggest round: $5.0MSeries A · Jul 2018
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20182020202220242026

$5.0MSeries A$3.3MVenture$1.0MRound

First round: Series A, $5.0M
Biggest round: $5.0M
Usual gap between rounds: 7.7 years

The rounds

Aug 2026
Round$1.0M
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $1.0M sold, first sale Aug 2026
Mar 2026
Venture$3.3M3 new
Source recordedSEC filing: $3.3M sold, first sale Feb 2026
Jul 2018
Series A$5.0M
No investor was named in the report.
Reported by FinSMEsSEC filing: $4.7M sold, first sale Jun 2018

Founders and team

From MedRhythms's own website: 2 founders, 6 on the team.

Brian HarrisCo-Founder, Chief Executive Officer; MedRhythms

Owen McCarthyCo-Founder; MedRhythms

Chrissy BellowsBoard Member
Craig WilliamsBoard Member
Lindsey SantiagoBoard Member
Max MichaudBoard Member
Rick GeiserBoard Member
Steve DemelloBoard Member

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2018Venture2026Round2026

Global Brain Corporation

Morningside Group

Advantage Capital

Everyone who backed them

Global Brain CorporationVC firm1round

Morningside GroupVC firm1round

Advantage CapitalCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists MedRhythms as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.